The guidance that this review was conducted to inform was published in July 2014. This recommends prasugrel 10mg in combination with aspirin as an option for preventing atherothrombotic events in adults with acute coronary syndrome (unstable angina, non-ST segment elevation myocardial infarction or ST segment elevation myocardial infarction) having primary or delayed percutaneous coronary intervention.